非小细胞肺癌,免疫疗法和肠道微生物群的影响
Muhammad Faheem Raziq1, Haseeb Manzoor1, Masood Ur Rehman Kayani2
1Metagenomics Discovery Lab, School of Interdisciplinary Engineering and Sciences (SINES), National University of Sciences and Technology (NUST), Srinagar Highway, Sector H-12, Islamabad, Pakistan.
Current microbiology
|July 29, 2025
概括
肠道微生物群影响非小细胞肺癌 (NSCLC) 治疗. 调节肠道细菌可能会改善对PD-1/PD-L1免疫疗法的反应,从而改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 微生物组研究 微生物组研究
背景情况:
- 非小细胞肺癌 (NSCLC) 是全球癌症死亡的主要原因,对一些患者的治疗疗效有限.
- 针对PD-1/PD-L1的免疫检查点抑制剂已经显示出希望,但面临着毒性和耐药性等挑战.
- 人们越来越认识到肠道微生物群是影响癌症免疫反应和治疗结果的关键因素.
研究的目的:
- 审查当前对肠道微生物群对NSCLC的影响的理解.
- 探索微生物组调制的潜力,以提高抗PD-1/PD-L1疗法的疗效.
- 为在个性化NSCLC治疗中整合基于微生物组的策略提供见解.
主要方法:
- 对研究肠道微生物组和NSCLC的文献综述.
- 对特定微生物 (如Akkermansia muciniphila) 的研究分析及其与免疫治疗反应的关联.
- 在NSCLC的背景下对微生物组-宿主-药物相互作用的证据综合.
主要成果:
- 特定的肠道微生物组成与患者对抗PD-1/PD-L1疗法的反应有关.
- 阿克尔曼西亚 (Akkermansia muciniphila) 和其他微生物可以预测或增强免疫疗法的有效性.
- 肠道微生物组失调可以对NSCLC的治疗结果产生负面影响.
结论:
- 肠道微生物组在调节对NSCLC治疗的免疫反应方面发挥着至关重要的作用.
- 针对肠道微生物组提供了一个有希望的策略,以克服免疫疗法耐药性并改善患者的治疗结果.
- 个性化,微生物组知情的方法对于优化NSCLC免疫疗法至关重要.
更多相关视频
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
1.1K
08:42Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)
Published on: June 27, 2025
579
相关概念视频
01:27Tumor Immunotherapy
662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662
02:17The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K